GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sirona Dental Systems Inc (NAS:SIRO) » Definitions » Beneish M-Score

Sirona Dental Systems (Sirona Dental Systems) Beneish M-Score : 0.00 (As of May. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Sirona Dental Systems Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Sirona Dental Systems's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Sirona Dental Systems was 0.00. The lowest was 0.00. And the median was 0.00.


Sirona Dental Systems Beneish M-Score Historical Data

The historical data trend for Sirona Dental Systems's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Dental Systems Beneish M-Score Chart

Sirona Dental Systems Annual Data
Trend Mar06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.49 -2.20 -2.64 -2.83 -2.35

Sirona Dental Systems Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.68 -2.81 -2.71 -2.35 -2.50

Competitive Comparison of Sirona Dental Systems's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Sirona Dental Systems's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Dental Systems's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sirona Dental Systems's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Sirona Dental Systems's Beneish M-Score falls into.



Sirona Dental Systems Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Sirona Dental Systems for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2758+0.528 * 0.9795+0.404 * 0.8743+0.892 * 1.0061+0.115 * 1.0331
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9996+4.679 * -0.023595-0.327 * 1.2117
=-2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec15) TTM:Last Year (Dec14) TTM:
Total Receivables was $202 Mil.
Revenue was 304.2 + 304.9 + 306.1 + 257.3 = $1,173 Mil.
Gross Profit was 174 + 166.9 + 174.6 + 143.8 = $659 Mil.
Total Current Assets was $876 Mil.
Total Assets was $1,873 Mil.
Property, Plant and Equipment(Net PPE) was $203 Mil.
Depreciation, Depletion and Amortization(DDA) was $68 Mil.
Selling, General, & Admin. Expense(SGA) was $353 Mil.
Total Current Liabilities was $303 Mil.
Long-Term Debt & Capital Lease Obligation was $0 Mil.
Net Income was 51.3 + 45.4 + 58.8 + 36 = $192 Mil.
Non Operating Income was 1.5 + -5.9 + -2.2 + -2 = $-9 Mil.
Cash Flow from Operations was 9.3 + 107.7 + 58.1 + 69.2 = $244 Mil.
Total Receivables was $158 Mil.
Revenue was 293 + 290 + 299.7 + 282.7 = $1,165 Mil.
Gross Profit was 162.9 + 159.9 + 167.6 + 151.5 = $642 Mil.
Total Current Assets was $708 Mil.
Total Assets was $1,794 Mil.
Property, Plant and Equipment(Net PPE) was $215 Mil.
Depreciation, Depletion and Amortization(DDA) was $75 Mil.
Selling, General, & Admin. Expense(SGA) was $351 Mil.
Total Current Liabilities was $240 Mil.
Long-Term Debt & Capital Lease Obligation was $0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(202.3 / 1172.5) / (157.6 / 1165.4)
=0.172537 / 0.135233
=1.2758

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(641.9 / 1165.4) / (659.3 / 1172.5)
=0.550798 / 0.562303
=0.9795

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (875.8 + 202.7) / 1873.3) / (1 - (708.2 + 215.2) / 1793.9)
=0.424278 / 0.485256
=0.8743

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1172.5 / 1165.4
=1.0061

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(75.2 / (75.2 + 215.2)) / (67.8 / (67.8 + 202.7))
=0.258953 / 0.250647
=1.0331

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(352.7 / 1172.5) / (350.7 / 1165.4)
=0.30081 / 0.300927
=0.9996

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 303.3) / 1873.3) / ((0 + 239.7) / 1793.9)
=0.161907 / 0.133619
=1.2117

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(191.5 - -8.6 - 244.3) / 1873.3
=-0.023595

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Sirona Dental Systems has a M-score of -2.46 suggests that the company is unlikely to be a manipulator.


Sirona Dental Systems Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Sirona Dental Systems's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Dental Systems (Sirona Dental Systems) Business Description

Traded in Other Exchanges
N/A
Address
Sirona Dental Systems Inc was founded in 1997 and completed an initial public offering of its common stock on July 1, 1997. The Company is a manufacturer of high-quality, dental equipment, and is engaged in developing, manufacturing and marketing solutions for dentists around the world. The Company provides products in each of its four product segments: Dental CAD/CAM Systems; Imaging Systems; Treatment Centers; and Instruments. The Company markets its products globally to dental practices, clinics and laboratories through an international network of distributors. The dental market encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Recent technological advancements in the dental equipment industry include 3D radiography, digital radiography, CAD/CAM technology, intra oral cameras and periodontal instruments. The market it serves comprises the whole working environment of a dentist or dental technician, including the dentist's chair, lights, imaging systems and dental CAD/CAM systems, instruments, as well as practice furniture and other dental or lab-based systems. Dental CAD/CAM Systems address the market for dental restorations, which includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic, metal or composite blocks. The Company has developed a range of imaging systems for 2D and 3D, panoramic and intra-oral applications that allow the dentist to accommodate the patient in a more efficient manner. Treatment Centers comprise products from basic dentist chairs to sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. In July 2008, the Company launched its new TENEO Treatment Center, which combines technology with a timeless design that provides both patient and dentist with the ultimate in convenience and comfort. The Company offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis. The instruments are supplemented by multi-function tips, supply and suction hoses, as well as care and hygiene systems for instrument preparation. Its product information is actively made available to business publications, dentists, journals, professional organizations and dental schools, and its website. Sirona distributes its products globally to dental practices, clinics and laboratories through an international network of more than 480 distributors. The Companys registered trademarks include, Sirona, CEREC, Orthophos, Heliodent, inLab, CDR, and Schick. It competes with different companies which include international companies as well as smaller companies that compete regionally or on a narrower product line. The Company is subject to government regulations applicable to all businesses
Executives
Kraemer Harry M Jansen Jr director DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Arthur D Kowaloff director DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Walter Petersohn officer: Executive VP of Sales C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
David Beecken director DENTSPLY SIRONA INC, 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Thomas Jetter director DENTSPLY SIRONA INC, 221 W PHILADELPHIA ST, SUITE 60W, YORK PA 17401-2991
Ulrich Michel officer: CFO and Exec. Vice President CHAUSEE DE WAVRE, 1789, CARE OF WABCO HOLDINGS INC, BRUSSELS C9 1160
Rainer Berthan officer: Executive VP C/O SIRONA DENTAL SYSTEMS, INC., FABRIKSTRASSE, BENSHEIM 2M 31D-64625
Jeffrey Slovin director, officer: Chief Executive Officer DENTSPLY SIRONA INC., 30-30 47TH AVE, SUITE 500, LONG ISLAND CITY NY 11101
Jonathan I Friedman officer: General Counsel and Secretary DENTSPLY SIRONA INC., 30-30 47TH AVENUE, SUITE 500, LONG ISLAND CITY NY 11101
Timothy P Sullivan director THREE FIRST NATIONAL PLZ, SUITE 3800, CHICAGO IL 60602
Simone Blank director, officer: Executive VP and CFO C/O SIRONA, WASSERFELDSTRASSE 30 A-5020, SALZBURG C4 5020
Nicholas W Alexos director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Stephen Rosenberg 10 percent owner 1004 FARNAM STREET, SUITE 400, OMAHA NE 68102
Uri Landesman director 230 PARK AVENUE, NEW YORK NY 10169

Sirona Dental Systems (Sirona Dental Systems) Headlines